Pyxis Oncology Reports Financial Results for the Second Quarter Ended June 30, 2022 and Provides Pipeline Update August 15, 2022
Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update November 17, 2021
Pyxis Oncology Names New CMO to Lead Development of Next-Gen Antibody-Drug Conjugates September 20, 2021
